Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anju Nohria, M.D.

Co-Author

This page shows the publications co-authored by Anju Nohria and Tomas Neilan.
Connection Strength

2.981
  1. Pericardial disease in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 Jun; 9(6).
    View in: PubMed
    Score: 0.245
  2. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis. J Am Coll Cardiol. 2021 Mar 30; 77(12):1503-1516.
    View in: PubMed
    Score: 0.242
  3. Electrocardiographic features of immune checkpoint inhibitor associated myocarditis. J Immunother Cancer. 2021 Mar; 9(3).
    View in: PubMed
    Score: 0.241
  4. Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis. J Am Heart Assoc. 2020 12; 9(23):e018306.
    View in: PubMed
    Score: 0.236
  5. Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):315-322.
    View in: PubMed
    Score: 0.234
  6. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. Circulation. 2020 06 16; 141(24):2031-2034.
    View in: PubMed
    Score: 0.229
  7. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020 05 07; 41(18):1733-1743.
    View in: PubMed
    Score: 0.228
  8. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. J Am Coll Cardiol. 2020 02 11; 75(5):467-478.
    View in: PubMed
    Score: 0.224
  9. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. J Immunother Cancer. 2019 02 22; 7(1):53.
    View in: PubMed
    Score: 0.209
  10. Case-control study of heart rate abnormalities across the breast cancer survivorship continuum. Cancer Med. 2019 01; 8(1):447-454.
    View in: PubMed
    Score: 0.207
  11. Ibrutinib-Associated Atrial Fibrillation. JACC Clin Electrophysiol. 2018 12; 4(12):1491-1500.
    View in: PubMed
    Score: 0.202
  12. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. J Am Coll Cardiol. 2018 04 24; 71(16):1755-1764.
    View in: PubMed
    Score: 0.196
  13. Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Mar 02; 77(8):1122-1134.
    View in: PubMed
    Score: 0.060
  14. Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer. JACC CardioOncol. 2020 Nov; 2(4):553-563.
    View in: PubMed
    Score: 0.059
  15. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin. 2020 11; 70(6):480-504.
    View in: PubMed
    Score: 0.058
  16. Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. Trends Cardiovasc Med. 2020 08; 30(6):315-325.
    View in: PubMed
    Score: 0.057
  17. Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series. Cardiooncology. 2019; 5:1.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.